Photodynamic Therapy and Central Serous Chorioretinopathy

Central serous chorioretinopathy is a common acquired maculopathy. Multiple studies showed that photodynamic therapy is useful treatment for acute and chronic central serous chorioretinopathy. The exact mechanism of photodynamic therapy in treating central serous chorioretinopathy is not clear, but...

Descripción completa

Detalles Bibliográficos
Autores principales: Siaudvytyte, Lina, Diliene, Vaida, Miniauskiene, Goda, Balciuniene, Vilma Jurate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical Hypothesis, Discovery & Innovation Ophthalmology 2012
Materias:
Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939727/
https://www.ncbi.nlm.nih.gov/pubmed/24600627
_version_ 1782305731664412672
author Siaudvytyte, Lina
Diliene, Vaida
Miniauskiene, Goda
Balciuniene, Vilma Jurate
author_facet Siaudvytyte, Lina
Diliene, Vaida
Miniauskiene, Goda
Balciuniene, Vilma Jurate
author_sort Siaudvytyte, Lina
collection PubMed
description Central serous chorioretinopathy is a common acquired maculopathy. Multiple studies showed that photodynamic therapy is useful treatment for acute and chronic central serous chorioretinopathy. The exact mechanism of photodynamic therapy in treating central serous chorioretinopathy is not clear, but it is thought to be caused by short-term choriocapillaris hypoperfusion and long-term choroidal vascular remodeling, leading to a reduction in choroidal congestion, vascular hyperpermeability and extravascular leakage. Furthermore, photodynamic therapy seems to be an effective means of improving or stabilizing visual acuity in patients with central serous chorioretinopathy.
format Online
Article
Text
id pubmed-3939727
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medical Hypothesis, Discovery & Innovation Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-39397272014-03-05 Photodynamic Therapy and Central Serous Chorioretinopathy Siaudvytyte, Lina Diliene, Vaida Miniauskiene, Goda Balciuniene, Vilma Jurate Med Hypothesis Discov Innov Ophthalmol Hypothesis Central serous chorioretinopathy is a common acquired maculopathy. Multiple studies showed that photodynamic therapy is useful treatment for acute and chronic central serous chorioretinopathy. The exact mechanism of photodynamic therapy in treating central serous chorioretinopathy is not clear, but it is thought to be caused by short-term choriocapillaris hypoperfusion and long-term choroidal vascular remodeling, leading to a reduction in choroidal congestion, vascular hyperpermeability and extravascular leakage. Furthermore, photodynamic therapy seems to be an effective means of improving or stabilizing visual acuity in patients with central serous chorioretinopathy. Medical Hypothesis, Discovery & Innovation Ophthalmology 2012 /pmc/articles/PMC3939727/ /pubmed/24600627 Text en © 2012, Medical Hypothesis, Discovery & Innovation (MEHDI) Ophthalmology Journal This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Hypothesis
Siaudvytyte, Lina
Diliene, Vaida
Miniauskiene, Goda
Balciuniene, Vilma Jurate
Photodynamic Therapy and Central Serous Chorioretinopathy
title Photodynamic Therapy and Central Serous Chorioretinopathy
title_full Photodynamic Therapy and Central Serous Chorioretinopathy
title_fullStr Photodynamic Therapy and Central Serous Chorioretinopathy
title_full_unstemmed Photodynamic Therapy and Central Serous Chorioretinopathy
title_short Photodynamic Therapy and Central Serous Chorioretinopathy
title_sort photodynamic therapy and central serous chorioretinopathy
topic Hypothesis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939727/
https://www.ncbi.nlm.nih.gov/pubmed/24600627
work_keys_str_mv AT siaudvytytelina photodynamictherapyandcentralserouschorioretinopathy
AT dilienevaida photodynamictherapyandcentralserouschorioretinopathy
AT miniauskienegoda photodynamictherapyandcentralserouschorioretinopathy
AT balciunienevilmajurate photodynamictherapyandcentralserouschorioretinopathy

Ejemplares similares